Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Single amino acid mutations, but not common polymorphisms, decrease the activity of CYP1B1 against

Jennifer S Mammen1, Gary S Pittman, Ying Li

  • 1Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, MD 21205, USA.

Carcinogenesis
|June 17, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of tobacco smoking on estimated telomere shortening and epigenetic age acceleration among human blood immune cell types.

Clinical epigenetics·2026
Same author

Treatment-refractory hypothyroidism: Don't just increase the dose.

Cleveland Clinic journal of medicine·2026
Same author

Decoding cellular stress states for toxicology using single-cell transcriptomics.

NAM journal·2026
Same author

Comparative 28-day mouse study of topically applied aryl hydrocarbon receptor ligands: microbiota-derived indoles, therapeutic tapinarof, pollutants 2,3,7,8-tetrachlorodibenzo-p-dioxin and diesel exhaust particles.

Chemico-biological interactions·2026
Same author

Decoding Cellular Stress States for Toxicology Using Single-Cell Transcriptomics.

bioRxiv : the preprint server for biology·2025
Same author

Does consumption of a high-fructose diet during pregnancy and lactation exacerbate the effects of maternal exposure to cadmium on development and metabolic function of mouse offspring?

Journal of toxicology and environmental health. Part A·2025

Rare genetic mutations in Cytochrome P450 1B1 (CYP1B1) significantly impair benzo[a]pyrene metabolism, increasing cancer susceptibility. Common CYP1B1 variants show minimal impact on this critical metabolic pathway.

Area of Science:

  • Biochemistry
  • Genetics
  • Toxicology

Background:

  • Inter-individual variation in carcinogen metabolism influences cancer susceptibility.
  • Cytochrome P450 1B1 (CYP1B1) is key in activating the environmental carcinogen benzo[a]pyrene (B[a]P).
  • Genetic variations in CYP1B1 can alter B[a]P metabolism and cancer risk.

Purpose of the Study:

  • To investigate the impact of rare mutations and common polymorphisms in CYP1B1 on benzo[a]pyrene metabolism.
  • To determine how specific CYP1B1 variants affect the enzymatic conversion of B[a]P-7,8-diol.
  • To assess the functional consequences of identified CYP1B1 genetic variants on enzyme activity.

Main Methods:

  • In vitro enzymatic assays using a Saccharomyces cerevisiae microsomal expression system.

Related Experiment Videos

  • Analysis of six rare CYP1B1 mutations and four common single nucleotide polymorphisms.
  • Michaelis-Menten kinetic analysis to determine enzyme parameters (KM, kcat, kcat/KM).
  • Allele frequency analysis in diverse human populations.
  • Main Results:

    • Five rare missense mutations and one deletion mutation in CYP1B1 drastically reduced enzyme activity (3-12% of normal or undetectable).
    • Common CYP1B1 polymorphisms (Arg48Gly, Ala199Ser, Val432Leu, Asn453Ser) exhibited modest effects on B[a]P-7,8-diol metabolism.
    • Michaelis-Menten analysis indicated a 2-fold lower KM for two specific haplotypes (RAVS, RALS), but this was not confirmed by direct rate measurements.
    • The Ser453 variant, present in RALS, showed varying frequencies across populations, being most common in Europeans (16%).

    Conclusions:

    • Rare, disease-associated CYP1B1 mutations significantly impair the metabolism of benzo[a]pyrene-7,8-diol, potentially increasing cancer risk.
    • Common CYP1B1 polymorphisms do not appear to substantially alter B[a]P-7,8-diol metabolism.
    • Further research is needed to fully elucidate the role of common CYP1B1 variants in cancer susceptibility.